Invention Grant
- Patent Title: Tricyclic lactones for treatment of cancer
- Patent Title (中): 三环内酯治疗癌症
-
Application No.: US13811015Application Date: 2011-07-18
-
Publication No.: US09150531B2Publication Date: 2015-10-06
- Inventor: Ritha Gidlöf , Martin Johansson , Olov Sterner , Eduardo Muñoz
- Applicant: Ritha Gidlöf , Martin Johansson , Olov Sterner , Eduardo Muñoz
- Applicant Address: SE Helsingborg
- Assignee: Glactone Pharma Development AB
- Current Assignee: Glactone Pharma Development AB
- Current Assignee Address: SE Helsingborg
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: SE1050815 20100719
- International Application: PCT/EP2011/062243 WO 20110718
- International Announcement: WO2012/010555 WO 20120126
- Main IPC: C07D303/40
- IPC: C07D303/40 ; C07D307/93 ; C07D303/38 ; A61K31/336 ; A61K31/365 ; A61K45/06
Abstract:
The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/NF-κB signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising such novel compounds, its use and a method thereof, is also disclosed.
Public/Granted literature
- US20130310451A1 TRICYCLIC LACTONES FOR TREATMENT OF CANCER Public/Granted day:2013-11-21
Information query
